MedinCell S.A. (EPA: MEDCL)
France
· Delayed Price · Currency is EUR 16.76
-0.04 (-0.24%)
Dec 23, 2024, 5:35 PM CET
MedinCell Income Statement
Financials in millions EUR. Fiscal year is April - March.
Millions EUR. Fiscal year is Apr - Mar.
Fiscal Year | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2019 - 2016 |
|---|---|---|---|---|---|---|---|
Period Ending | Sep '24 Sep 30, 2024 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 | Mar '21 Mar 31, 2021 | Mar '20 Mar 31, 2020 | 2019 - 2016 |
| Operating Revenue | 10.67 | 9.03 | 9.89 | 4.09 | 8.19 | 2.85 | Upgrade
|
| Other Revenue | 2.53 | 2.91 | 3.77 | 4.25 | - | 3.15 | Upgrade
|
| Revenue | 13.2 | 11.95 | 13.66 | 8.34 | 8.19 | 6 | Upgrade
|
| Revenue Growth (YoY) | -6.56% | -12.52% | 63.77% | 1.86% | 36.43% | 48.26% | Upgrade
|
| Gross Profit | 13.2 | 11.95 | 13.66 | 8.34 | 8.19 | 6 | Upgrade
|
| Selling, General & Admin | 12.51 | 11.79 | 9.72 | 8.49 | 7.44 | 7.96 | Upgrade
|
| Research & Development | 20.18 | 21.05 | 27.92 | 23.58 | 19.54 | 17.21 | Upgrade
|
| Other Operating Expenses | 0.09 | 0.04 | 0.04 | 0.08 | 0.13 | 0.01 | Upgrade
|
| Operating Expenses | 32.78 | 32.89 | 37.68 | 32.15 | 27.11 | 25.18 | Upgrade
|
| Operating Income | -19.58 | -20.94 | -24.03 | -23.81 | -18.93 | -19.18 | Upgrade
|
| Interest Expense | -4.73 | -4.62 | -3.93 | -1.84 | -3.58 | -2.11 | Upgrade
|
| Interest & Investment Income | 1.14 | 0.55 | 0.04 | 0.05 | 0.04 | 0.06 | Upgrade
|
| Currency Exchange Gain (Loss) | -0.83 | 0.14 | 1.17 | 0.83 | -0.23 | 0.08 | Upgrade
|
| Other Non Operating Income (Expenses) | -7.28 | -0.04 | -5.21 | -0.02 | 0.36 | -0.14 | Upgrade
|
| EBT Excluding Unusual Items | -31.29 | -24.91 | -31.95 | -24.8 | -22.34 | -21.29 | Upgrade
|
| Gain (Loss) on Sale of Investments | - | - | -0.04 | - | - | - | Upgrade
|
| Asset Writedown | - | - | - | - | - | -0.05 | Upgrade
|
| Other Unusual Items | 0.06 | -0.04 | -0.02 | -0 | 3.35 | -0.1 | Upgrade
|
| Pretax Income | -31.23 | -24.95 | -32.01 | -24.81 | -18.99 | -21.44 | Upgrade
|
| Income Tax Expense | 0.22 | 0.09 | - | - | - | 2.47 | Upgrade
|
| Earnings From Continuing Operations | -31.45 | -25.04 | -32.01 | -24.81 | -18.99 | -23.92 | Upgrade
|
| Net Income | -31.45 | -25.04 | -32.01 | -24.81 | -18.99 | -23.92 | Upgrade
|
| Net Income to Common | -31.45 | -25.04 | -32.01 | -24.81 | -18.99 | -23.92 | Upgrade
|
| Shares Outstanding (Basic) | 29 | 28 | 25 | 25 | 22 | 20 | Upgrade
|
| Shares Outstanding (Diluted) | 29 | 28 | 25 | 25 | 22 | 20 | Upgrade
|
| Shares Change (YoY) | 9.39% | 12.83% | 1.39% | 12.79% | 9.52% | 16.53% | Upgrade
|
| EPS (Basic) | -1.08 | -0.88 | -1.27 | -1.00 | -0.86 | -1.19 | Upgrade
|
| EPS (Diluted) | -1.08 | -0.88 | -1.27 | -1.00 | -0.86 | -1.19 | Upgrade
|
| Free Cash Flow | 21.03 | -12.25 | -21.58 | -22.99 | -12.78 | -13.11 | Upgrade
|
| Free Cash Flow Per Share | 0.72 | -0.43 | -0.86 | -0.93 | -0.58 | -0.65 | Upgrade
|
| Gross Margin | 100.00% | 100.00% | 100.00% | 100.00% | 100.00% | 100.00% | Upgrade
|
| Operating Margin | -148.34% | -175.30% | -175.94% | -285.58% | -231.21% | -319.58% | Upgrade
|
| Profit Margin | -238.24% | -209.61% | -234.42% | -297.51% | -231.93% | -398.58% | Upgrade
|
| Free Cash Flow Margin | 159.31% | -102.52% | -158.04% | -275.67% | -156.11% | -218.57% | Upgrade
|
| EBITDA | -18.81 | -20.05 | -23.05 | -22.95 | -18.12 | -18.37 | Upgrade
|
| EBITDA Margin | -142.50% | -167.82% | -168.81% | -275.23% | -221.40% | - | Upgrade
|
| D&A For EBITDA | 0.77 | 0.89 | 0.97 | 0.86 | 0.8 | 0.81 | Upgrade
|
| EBIT | -19.58 | -20.94 | -24.03 | -23.81 | -18.93 | -19.18 | Upgrade
|
| EBIT Margin | -148.34% | -175.30% | -175.94% | -285.58% | -231.21% | - | Upgrade
|
| Revenue as Reported | 13.2 | 11.95 | 13.66 | 8.34 | 11.78 | 6 | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.